Ginkgo Bioworks Holdings, Inc.DNANYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +26.16% | +27.34% | -11.75% | -56.39% | -23.84% |
| Gross Profit Growth | +21.61% | +26.20% | -18.13% | -67.07% | +21.39% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +5.67% | +8.64% | +6.87% | +6.50% | +6.87% |
| Weighted Average Shares Diluted Growth | +4.90% | +8.50% | +6.78% | +6.48% | +6.87% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +25.39% | +10.63% | +22.42% | -10.49% | +7.05% |
| Inventory Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -17.29% | -18.23% | -24.26% | -19.70% | -18.71% |
| Book Value per Share Growth | -38.24% | -39.64% | -31.15% | -34.13% | -33.54% |
| Debt Growth | +95.45% | +85.32% | -5.18% | -5.10% | -10.83% |
| R&D Expense Growth | -34.74% | -48.03% | -60.24% | -9.94% | -34.37% |
| SG&A Expenses Growth | -35.78% | -30.22% | -34.71% | -14.03% | -19.69% |